Kintor Pharmaceutical Ltd 2023 Sustainability Report
Company: Kintor Pharmaceutical Ltd
Sector: Manufacturing
Country: China
Year: 2023
Type: Sustainability Report
Pages: 55
The report presents the Group's 2023 ESG management across environmental, social and governance topics, with the Board assuming full responsibility for ESG issues. Total Scope 1 and Scope 2 emissions were 3,719.63 ton and energy consumption was 6,238.9 MWh. The Group reported 225 employees, 100% training coverage and 41.5 hours average training per person. No work-related fatalities occurred during the Year, and the Group set an emission reduction target of not lower than 2% for the end of December 2024.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.